Literature DB >> 16785513

Increased level and longevity of protective immune responses induced by DNA vaccine expressing the HIV-1 Env glycoprotein when combined with IL-21 and IL-15 gene delivery.

Elizabeth Bolesta1, Aleksandra Kowalczyk, Andrzej Wierzbicki, Cheryl Eppolito, Yutaro Kaneko, Masafumi Takiguchi, Leonidas Stamatatos, Protul A Shrikant, Danuta Kozbor.   

Abstract

We investigated the ability of a plasmid-derived IL-21 delivered alone or in combination with the IL-15 gene to regulate immune responses to the HIV-1 envelope (Env) glycoprotein induced by DNA vaccination. Mice were injected with the gp140DeltaCFI(HXB2/89.6) vector expressing a modified Env glycoprotein with C-terminal mutations intended to mimic a fusion intermediate, in which the most divergent region encoding the variable V1, V2, and V3 domains of CXCR4-tropic HxB2 virus was replaced with the dual-tropic 89.6 viral strain. Using a recombinant vaccinia virus expressing 89.6 Env glycoprotein (vBD3) in a mouse challenge model, we observed that IL-21 plasmid produced sustained resistance to viral transmission when injected 5 days after DNA vaccination. Moreover, IL-21 in a synergistic manner with IL-15 expression vector augmented the vaccine-induced recall responses to the vBD3 challenge compared with those elicited by immunization in the presence of either cytokine alone. The synergistic combination of IL-21 and IL-15 plasmids promoted expansion of CD8+CD127+ memory T cell pools specific for a subdominant HLA-A2-restricted Env(121-129) epitope (KLTPLCVTL). Our results also show that coimmunization with IL-21 and IL-15 plasmid combination resulted in enhanced CD8+ T cell function that was partially independent of CD4+ T cell help in mediating protection against vBD3 challenge. Furthermore, the use of IL-21 and IL-15 genes was able to increase Ab-dependent cellular cytotoxicity and complement-dependent lysis of Env-expressing target cells through augmentation of Env-specific IgG Ab levels. These data indicate that the plasmid-delivered IL-21 and IL-15 can increase the magnitude of the response to DNA vaccines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785513      PMCID: PMC2504862          DOI: 10.4049/jimmunol.177.1.177

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  88 in total

1.  Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses.

Authors:  P L Earl; S Koenig; B Moss
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

2.  Higher level expression of lymphocyte function-associated antigen-1 (LFA-1) on in vivo natural killer cells.

Authors:  T Nishimura; T Itoh
Journal:  Eur J Immunol       Date:  1988-12       Impact factor: 5.532

Review 3.  Life span of naive and memory T cells.

Authors:  D F Tough; J Sprent
Journal:  Stem Cells       Date:  1995-05       Impact factor: 6.277

Review 4.  IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels.

Authors:  Y Tagaya; R N Bamford; A P DeFilippis; T A Waldmann
Journal:  Immunity       Date:  1996-04       Impact factor: 31.745

5.  IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation.

Authors:  R J Armitage; B M Macduff; J Eisenman; R Paxton; K H Grabstein
Journal:  J Immunol       Date:  1995-01-15       Impact factor: 5.422

6.  Antiviral protection by CD8+ versus CD4+ T cells. CD8+ T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4-dependent IL.

Authors:  D Binder; T M Kündig
Journal:  J Immunol       Date:  1991-06-15       Impact factor: 5.422

7.  A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors.

Authors:  B J Doranz; J Rucker; Y Yi; R J Smyth; M Samson; S C Peiper; M Parmentier; R G Collman; R W Doms
Journal:  Cell       Date:  1996-06-28       Impact factor: 41.582

8.  Natural cytotoxic T cells responsible for anti-CD3-induced cytotoxicity in mice.

Authors:  Y Yanagita; T Nishimura; X H Gao; T Mitomi; S Habu
Journal:  Immunol Lett       Date:  1992-02       Impact factor: 3.685

9.  Virus-specific CD8+ T-cell memory determined by clonal burst size.

Authors:  S Hou; L Hyland; K W Ryan; A Portner; P C Doherty
Journal:  Nature       Date:  1994-06-23       Impact factor: 49.962

10.  Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division.

Authors:  L H Boise; A J Minn; C H June; T Lindsten; C B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

View more
  20 in total

1.  IL-15 increases the frequency of effector memory CD8+ T cells in rhesus monkeys immunized with HIV vaccine.

Authors:  Shirui Li; Xiangrong Qi; Yingying Gao; Yanling Hao; Lianxian Cui; Li Ruan; Wei He
Journal:  Cell Mol Immunol       Date:  2010-09-27       Impact factor: 11.530

2.  In vitro restoration of Th17 response during HIV infection with an antiretroviral drug and Th17 differentiation cytokines.

Authors:  Yelina Alvarez; Michael Tuen; Arthur Nàdas; Catarina E Hioe
Journal:  AIDS Res Hum Retroviruses       Date:  2011-12-01       Impact factor: 2.205

Review 3.  New players in cytokine control of HIV infection.

Authors:  Massimo Alfano; Andrea Crotti; Elisa Vicenzi; Guido Poli
Journal:  Curr HIV/AIDS Rep       Date:  2008-02       Impact factor: 5.071

4.  Modification of one epitope-flanking amino acid allows for the induction of friend retrovirus-specific CD8+ T cells by Adenovirus-based immunization.

Authors:  Philipp Gödel; Sonja Windmann; Kirsten K Dietze; Ulf Dittmer; Wibke Bayer
Journal:  J Virol       Date:  2012-08-29       Impact factor: 5.103

5.  Expression of interleukin-15 and interleukin-15Rα in monocytes of HIV type 1-infected patients with different courses of disease progression.

Authors:  Maciej Tarkowski; Laurenzia Ferraris; Sara Martone; Francesco Strambio de Castillia; Donatella Misciagna; Renata I Mazzucchelli; Emanuela Lattuada; Giuseppe Paraninfo; Massimo Galli; Agostino Riva
Journal:  AIDS Res Hum Retroviruses       Date:  2011-09-23       Impact factor: 2.205

6.  Human immunodeficiency virus and leishmaniasis.

Authors:  Navid Ezra; Maria Teresa Ochoa; Noah Craft
Journal:  J Glob Infect Dis       Date:  2010-09

Review 7.  Cytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccines.

Authors:  Morgan A Reuter; Carolina Pombo; Michael R Betts
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-27       Impact factor: 7.638

8.  Improvement in efficacy of DNA vaccine encoding HIV-1 Vif by LIGHT gene adjuvant.

Authors:  Jiani Du; Xiaoyu Wu; Fengying Long; Jiejun Wen; Wenli Hao; Ran Chen; Xiaobo Kong; Min Qian; Wenzheng Jiang
Journal:  Viral Immunol       Date:  2013-01-18       Impact factor: 2.257

9.  IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses.

Authors:  Yvonne M Mueller; Duc H Do; Susan R Altork; Carol M Artlett; Edward J Gracely; Christos D Katsetos; Agustin Legido; Francois Villinger; John D Altman; Charles R Brown; Mark G Lewis; Peter D Katsikis
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

10.  Targeting a mimotope vaccine to activating Fcgamma receptors empowers dendritic cells to prime specific CD8+ T cell responses in tumor-bearing mice.

Authors:  Margaret Gil; Magdalena Bieniasz; Andrzej Wierzbicki; Barbara J Bambach; Hanna Rokita; Danuta Kozbor
Journal:  J Immunol       Date:  2009-10-21       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.